Chloroethylclonidine binds irreversibly to exposed cysteines in the fifth membrane-spanning domain of the human α2(A)-adrenergic receptor

Molecular Pharmacology

Volumn 53, Issue 3, 1998, Pages 370-376

  Marjamäki, Anne ^a,d   Pihlavisto, Marjo ^a   Cockcroft, Victor ^b,c   Heinonen, Petri ^a   Savola, Juha Matti ^b,c   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ORION CORPORATION   (Finland)

^c Oy Juvantia Pharma Ltd   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; CLONIDINE; RECEPTOR SUBTYPE;

ALPHA HELIX; ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; COVALENT BOND; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; LIGAND BINDING; LIPID BILAYER; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR AFFINITY; SECOND MESSENGER; SITE DIRECTED MUTAGENESIS;

EID: 0345259510     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.3.370     Document Type: Article

References (33)

1. Baldwin JM (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-1703.
2. Befort K, Tabbara L, Bausch S, Chavkin C, Evans C, and Keiffer B (1996) The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol Pharmacol 49:216-223.
3. 2C-adrenergic receptor from the OK cell line. Mol Pharmacol 45:176-181.
4. 1B-adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes. FEBS Lett 399:9-13.
5. 2C2 adrenoceptor subtype gene. Biochim Biophys Acta 1171:219-223.
6. Fong TM, Yu H, and Strader CD (1992) Molecular basis for species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. J Biol Chem 267: 25668-25671.
7. Fu D, Ballesteros JA, Weinstein H, Chen J, and Javitch JA (1996) Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. Biochemistry 35:11278-11285.
8. 2-adrenergic receptor. J Biol Chem 265:17307-17317.
9. 3H]RX821002 as radioligands. Biochim Biophys Acta 1266:207-214.
10. 1-adrenergic receptors revealed by chlorethylclonidine. Mol Pharmacol 32:505-510.
11. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Backmann E, and Downing KH (1990) Model for structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy. J Mol Biol 213:899-929.
12. 1-adrenergic receptor subtype selective agonist binding. J Biol Chem 270:23189-23195.
13. 2-adrenoceptor subtypes to regulation of cAMP-production in transfected S115 cells. Eur J Pharmacol 266:165-174.
14. Javitch JA, Fu D, and Chen J (1995) Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. Biochemistry 34:16433-16439.
15. 2-adrenergic receptor. Science (Washington DC) 238:650-656.
16. 2-adrenergic receptor. J Biol Chem 266:10470-10478 .
17. 2C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42:16-27.
18. 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci USA 87:5094-5098.
19. 2-adrenoceptors to characterize subtype selectivity of antagonist binding. Eur J Pharmacol 246:219-226.
20. McPherson GA (1985) Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J Pharmacol Methods 14:213-229.
21. 2-adrenoceptor subtypes. Mol Pharmacol 44:1165-1170.
22. Pepperl DJ and Regan JW (1994) Adrenergic receptors, in Handbook of Receptors and Channels (Peroutka SJ, ed) pp 45-78, CRC Press, Boca Raton.
23. 2-adrenergic receptor subtype. Proc Natl Acad Sci USA 85:6301-6305
24. Sachais B, Snider R, Lowe J, and Krause J (1993) Molecular basis for the species selectivity of the substance P antagonist CP-96345. J Biol Chem 268:2319-2323.
25. Savarese TM and Fraser CM (1992) In vitro mutagenesis and the search for structure-function relationships among G protein coupled receptors. Biochem J 283:1-19.
26. 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J 15:3566-3578 .
27. Schwartz TW (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol 5:434-444.
28. Strader CD, Candelore MR, Hill WS, Sigal IS, and Dixon RAF (1989) Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J Biol Chem 264:13572-1357.
29. 2-adrenoceptor. Br J Pharmacol 110:54-60.
30. Tian WN, Gupta S, and Deth RC (1990) Species differences in chlorethylclonidine antagonism at vascular alpha1 adrenergic receptors. J Pharmacol Exp Ther 253: 877-883.
31. Vargas HM, Cunningham D, Zhou L, Hartman HB, and Gorman AJ (1993) Cardiovascular effects of chloroethylclonidine, an irreversible α1B adrenoceptor antagonist, in the unanesthetized rat: a pharmacological analysis in vivo and in vitro. J Pharmacol Exp Ther 266:864-871.
32. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol 40:168-179.
33. 2B-adrenergic receptor. Proc Natl Acad Sci USA 87:3102-3106.